Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 6Lung Neoplasms 3Breast Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Tobacco Use Disorder 1Tobacco Use Cessation 1Substance-Related Disorders 1Smoking Cessation 1Smoking 1Sedentary Behavior 1Patient Acceptance of Health Care 1Motor Activity 1Lung Cancer Screening 1Hematologic Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Depression 1Death 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Cancer Patients 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Paclitaxel 95Carboplatin 76pembrolizumab 72Cisplatin 28Bevacizumab 27Letrozole 22Radiotherapy 21Doxorubicin 21Megestrol Acetate 20lenvatinib 19olaparib 18Taxes 17Docetaxel 17Nivolumab 16Specimen Handling 15Metformin 15dostarlimab 14Magnetic Resonance Spectroscopy 14Gemcitabine 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11Biopsy 11temsirolimus 10abemaciclib 10atezolizumab 9Radiation 9Early Intervention, Educational 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Endometrial Neoplasms × Focus Groups × Clear all
NCT04474184 2023-11-18

Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates

Mayo Clinic

Phase 1 Completed
33 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡